Myeloperoxidase (MPO) is an important component of thehuman innateimmune system and the main source of a strong oxidizing and chlorinatingspecies, hypochlorous acid (HOCl). Inadvertent, misplaced, or excessivegeneration of HOCl by MPO is associated with multiple human inflammatorydiseases. Therefore, there is a considerable interest in the developmentof MPO inhibitors. Here, we report the synthesis and characterizationof a boronobenzyl derivative of acetaminophen (AMBB), which can functionas a proinhibitor of MPO and release acetaminophen, the inhibitorof chlorination cycle of MPO, in the presence of inflammatory oxidants,i.e., hydrogen peroxide, hypochlorous acid, or peroxynitrite. We demonstratethat the AMBB proinhibitor undergoes conversion to acetaminophen byall three oxidants, with the involvement of the primary phenolic productintermediate, with relatively long half-life at pH 7.4. The determinedrate constants of the reaction of the AMBB proinhibitor with hydrogenperoxide, hypochlorous acid, or peroxynitrite are equal to 1.67, 1.6x 10(4), and 1.0 x 10(6) M-1 s(-1), respectively. AMBB showed lower MPO inhibitoryactivity (IC50 > 0.3 mM) than acetaminophen (IC50 = 0.14 mM) toward MPO-dependent HOCl generation. Finally,basedon the determined reaction kinetics and the observed inhibitory effectsof two plasma components, uric acid and albumin, on the extent ofAMBB oxidation by ONOO- and HOCl, we conclude thatONOO(-) is the most likely potential activator ofAMBB in human plasma.